LAX.SH
ERIS LIFESCIENCES LIMITED·PHARMACEUTICALS 66.37·Pharmaceuticals & Biotechnology Companies
Price
1,121.2
-1.33%52W Range
Market Cap
₹15,537.96 Cr
Traded: ₹3.35 Cr (0.02%) 0.0x
Free Float: ₹562.47 Cr (0.60% of FF traded)
Volume · 60D trend
29.72 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Profit | +17.0% | +12.0% | +19.0% | -- | +69.0% | Accelerating |
| Sales | +18.0% | +21.0% | +23.0% | -- | +10.0% | Stable |
| ROE | +21.0% | +18.0% | +16.0% | -- | -- | Decelerating |
| Return | -- | +13.0% | +23.0% | -20.0% | -- | Stable |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 873 | 757 | 807 | 792 | 773 | 705 | 727 | 741 | 720 | 551 | 486 | 505 | 467 | 403 | 423 | 461 |
| Expenses | 577 | 484 | 526 | 504 | 496 | 453 | 477 | 477 | 470 | 402 | 311 | 324 | 297 | 284 | 286 | 309 |
| Operating Profit | 296 | 272 | 282 | 288 | 277 | 252 | 250 | 265 | 250 | 148 | 176 | 181 | 170 | 119 | 137 | 151 |
| Other Income | 2 | 2 | -17 | 3 | 4 | 8 | 4 | 5 | 2 | 15 | 4 | 3 | 1 | 1 | 2 | 5 |
| Interest | 47 | 46 | 49 | 50 | 49 | 54 | 57 | 59 | 60 | 33 | 18 | 16 | 17 | 9 | 3 | 7 |
| Depreciation | 72 | 70 | 70 | 69 | 71 | 77 | 81 | 80 | 76 | 54 | 46 | 42 | 41 | 35 | 30 | 29 |
| Profit Before Tax | 179 | 159 | 145 | 173 | 161 | 129 | 116 | 129 | 116 | 77 | 116 | 126 | 112 | 76 | 107 | 121 |
| Tax % | 20.0% | -75.0% | 25.0% | 22.0% | 22.0% | 21.0% | 25.0% | 25.0% | 22.0% | -4.0% | 12.0% | 3.0% | 17.0% | 19.0% | 6.0% | 1.0% |
| Net Profit | 143 | 279 | 109 | 134 | 125 | 102 | 87 | 96 | 90 | 80 | 101 | 122 | 94 | 61 | 100 | 119 |
| Exceptional Items | -- | 0 | -17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- |
| EPS (Rs) | 10.3 | 20.3 | 7.3 | 8.8 | 8.7 | 6.9 | 6.2 | 6.7 | 6.1 | 5.2 | 7.5 | 9.1 | 7.0 | 4.8 | 7.5 | 8.8 |
| Sales Growth (YoY) | 12.9% | 7.4% | 11.0% | 6.9% | 7.4% | 27.9% | 49.6% | 46.7% | 54.2% | 36.7% | 14.9% | 9.5% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 15.3% | -6.2% | 1.9% | 2.5% | 9.7% | -3.0% | -1.9% | 2.9% | 30.7% | 13.4% | -3.8% | 8.1% | 15.9% | -4.7% | -8.2% | -- |
| OP Growth (YoY) | 6.9% | 7.9% | 12.8% | 8.7% | 10.8% | 70.3% | 42.0% | 46.4% | 47.1% | 24.4% | 28.5% | 19.9% | -- | -- | -- | -- |
| OP Growth (QoQ) | 8.8% | -3.5% | -2.1% | 4.0% | 9.9% | 0.8% | -5.7% | 6.0% | 68.9% | -15.9% | -2.8% | 6.5% | 42.9% | -13.1% | -9.3% | -- |
| Profit Growth (YoY) | -- | 200.0% | 33.0% | 31.0% | 42.0% | 32.0% | -18.0% | -26.0% | -12.0% | 9.0% | 1.0% | 3.0% | 0.0% | -19.0% | 1.0% | 2.0% |
| EPS Growth (YoY) | 18.7% | 195.1% | 19.0% | 31.1% | 41.5% | 32.0% | -18.5% | -25.8% | -12.3% | 8.5% | 0.8% | 2.5% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -49.4% | 177.7% | -17.0% | 1.9% | 25.7% | 12.0% | -8.6% | 10.0% | 17.2% | -30.9% | -16.8% | 29.9% | 45.1% | -35.8% | -15.4% | -- |
| OP Margin | 33.9% | 35.9% | 34.9% | 36.4% | 35.8% | 35.7% | 34.4% | 35.8% | 34.7% | 26.9% | 36.2% | 35.8% | 36.4% | 29.5% | 32.4% | 32.8% |
| Net Margin | 16.4% | 36.9% | 13.5% | 16.9% | 16.2% | 14.5% | 12.0% | 13.0% | 12.5% | 14.5% | 20.8% | 24.2% | 20.1% | 15.1% | 23.6% | 25.8% |
| Material Cost % | -- | 24.5% | 27.6% | 25.5% | 23.9% | 24.1% | 24.3% | 25.1% | 25.1% | 21.4% | 18.3% | 18.7% | 16.8% | 18.1% | 21.0% | 23.0% |
| Employee Cost % | -- | 18.1% | 17.1% | 17.4% | 18.7% | 17.2% | 17.2% | 16.9% | 18.4% | 18.6% | 20.3% | 19.5% | 22.3% | 21.3% | 20.6% | 20.7% |
| P/S | 4.81 | 6.16 | 6.02 | 6.17 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 23.98 | 30.82 | 42.16 | 44.51 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 3.98 | 4.94 | 5.99 | 5.98 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50As Attached
As Attached
Eris Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve Financial Results
As Attached
As Attached
As Attached
As attached
as attached
As Attached
Eris Lifesciences Limited has informed the exchange about Rumor verification-Regulation 30 (11)
As attached
As Attached
as attached
as attached.
as attached
as attached
as attached
As Attached
As Attached
as attached
As Attached
as attached
As Attached
Eris Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve the financial results for ....
As attached
As attached
as attached
as attached
As Attached
As Attached
As Attached
As Attached
as attached
as attached
As Attached
as attached
as attached
as attached
as attached
as attached
As Attached
Eris Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve Financial Results and Interim Dividend
As Attached
As Attached
as attached
As Attached
As attached
As Attached
As Attached
As Attached
Annual Reports
9Credit Ratings
6Concalls
41Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024Jun 2024
30 Jun 2024Mar 2024
31 Mar 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Mar 2023
31 Mar 2023Jan 2023
31 Jan 2023Oct 2022
31 Oct 2022Aug 2022
31 Aug 2022May 2022
31 May 2022Feb 2022
28 Feb 2022Jan 2022
31 Jan 2022Oct 2021
31 Oct 2021Aug 2021
31 Aug 2021Jul 2021
31 Jul 2021May 2021
31 May 2021Mar 2021
31 Mar 2021Jan 2021
31 Jan 2021Nov 2020
30 Nov 2020Aug 2020
31 Aug 2020Jun 2020
30 Jun 2020Jun 2020
30 Jun 2020Feb 2020
29 Feb 2020Nov 2019
30 Nov 2019Jul 2019
31 Jul 2019May 2019
31 May 2019Jan 2019
31 Jan 2019Nov 2018
30 Nov 2018Aug 2018
31 Aug 2018May 2018
31 May 2018Feb 2018
28 Feb 2018Nov 2017
30 Nov 2017Aug 2017
31 Aug 2017Held by ETFs
14 ETFs hold ERIS · sorted by weight
Held by Mutual Funds
51 schemes hold ERIS · sorted by weight